Current share price for EMD : $0.053 0.001 (1.92%)
Emyria Limited (EMD, formerly Emerald Clinics Limited) is a clinical drug development and care delivery company focused on accelerating drug development and improving patient outcomes in neuroscience and mental health via Drug Development, New Drug Discovery and Proprietary Real-World Data (RWD).
Offer Open Date | 19 Dec 2019 |
Offer Close Date | 17 Jan 2020 |
Listing Date | 12 Feb 2020 |
Issue Price | $0.20 |
Amount Raised | $8,000,000 |
Shares Issued (new) | 40,000,000 |
Underwriter | |
Consultants | |
Auditor | Stantons International Audit and Consulting Pty Ltd |
Current Price | $0.05 | -73.50% |
First Day Open | n/a | n/a |
First Day High | n/a | n/a |
First Day Low | n/a | n/a |
First Day Close | n/a | n/a |
All-time High | $0.51 | 152.50% |
All-time Low | -100% | |
12-month High | $0.15 | -27.50% |
12-month Low | -100% |
Security Code | Company | Offer Open | Offer Close | Listing | Issue Price | Current Price | Gain |
---|---|---|---|---|---|---|---|
ATEC | BetaShares S&P/ASX Australian Technology ETF | 5 Mar 2020 | $24.21 | ||||
FANG | ETFS FANG+ ETF | 2 Mar 2020 | $25.55 | ||||
KAU | Kaiser Reef Limited | 13 Dec 2019 | 7 Feb 2020 | 28 Feb 2020 | $0.20 | $0.15 | -27.50% |
LGP | Little Green Pharma Ltd | 7 Jan 2020 | 29 Jan 2020 | 20 Feb 2020 | $0.45 | $0.13 | -71.11% |
AND | thedocyard Limited | 28 Nov 2019 | 31 Jan 2020 | 14 Feb 2020 | $0.20 | $2.32 | 1,060% |
CST | Castile Resources Ltd | 11 Dec 2019 | 24 Jan 2020 | 14 Feb 2020 | $0.20 | $0.09 | -53.50% |
EBND | VanEck Emerging Income Opportunities Active ETF (M | 13 Feb 2020 | $10.16 | ||||
CBE | Cobre Limited | 16 Dec 2019 | 6 Jan 2020 | 31 Jan 2020 | $0.20 | $0.07 | -63% |
COS | COSOL Limited | 18 Dec 2019 | 20 Dec 2019 | 24 Jan 2020 | $0.20 | $1.02 | 410% |
HVM | Happy Valley Nutrition Limited | 25 Nov 2019 | 4 Dec 2019 | 23 Jan 2020 | $0.20 | $0.01 | -94% |
NYR | Nyrada Inc | 4 Dec 2019 | 16 Dec 2019 | 16 Jan 2020 | $0.20 | $0.07 | -67.50% |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.